Roche receives FDA Emergency Use Authorization for new test to measure the level of SARS-CoV-2 antibodies

    NEXT STORY
    Roche announces FDA approval of Gavreto (pralsetinib) for people with advanced or metastatic RET-mutant and RET fusion-positive thyroid cancers
    PREV STORY
    Burning Rock Announces Proposed Registered Secondary Public Offering of American Depositary Shares
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Tetra Bio-Pharma’s Management Provides Corporate Update Ahead of Annual General Meeting

    author_avatar
    NASDAQ Market News

    BioNTech Announces Third Quarter 2020 Financial Results and Corporate Progress

    author_avatar
    NASDAQ Market News

    Progenics Pharmaceuticals Announces First Quarter 2019 Financial Results and Business Update

    author_avatar
    NASDAQ Market News